ISRG - Intuitive Surgical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
528.81
-7.82 (-1.46%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close536.63
Open533.25
Bid0.00 x 900
Ask0.00 x 800
Day's Range525.37 - 544.85
52 Week Range430.24 - 589.32
Volume1,420,868
Avg. Volume815,315
Market Cap61.051B
Beta (3Y Monthly)1.29
PE Ratio (TTM)52.21
EPS (TTM)10.13
Earnings DateOct 16, 2019 - Oct 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est585.75
Trade prices are not sourced from all markets
  • When To Sell Growth Stocks: How To Use A Carefully Drawn Trend Line
    Investor's Business Daily8 hours ago

    When To Sell Growth Stocks: How To Use A Carefully Drawn Trend Line

    Learn the concept of drawing a good trend line along three lows in the stock's weekly chart. It can help you decide when to sell the best growth stocks.

  • 3 Stocks I'm Never Selling
    Motley Fool20 hours ago

    3 Stocks I'm Never Selling

    Their competitive advantages and long-term growth prospects make these three stocks keepers.

  • When To Buy Growth Stocks: Some Leaders Can Still Run After Forming Late Stage Bases
    Investor's Business Daily3 days ago

    When To Buy Growth Stocks: Some Leaders Can Still Run After Forming Late Stage Bases

    While Intuitive Surgical showed why late-stage bases are an excellent topping signal, it also proves how some great companies can eventually lead again.

  • How One Key Metric Weighed On Intuitive Surgical's Attempted Breakout
    Investor's Business Daily3 days ago

    How One Key Metric Weighed On Intuitive Surgical's Attempted Breakout

    Intuitive Surgical stock attempted a breakout Friday after the robotic surgery giant topped second-quarter earnings and sales estimates, though it saw a moderation in hernia procedures.

  • Intuitive Surgical Earnings: ISRG Stock Down Despite Q2 Profit Beat
    InvestorPlace3 days ago

    Intuitive Surgical Earnings: ISRG Stock Down Despite Q2 Profit Beat

    Intuitive Surgical (NASDAQ:ISRG) reported its latest quarterly earnings results today, which included a profit that increased year-over-year, yet the business' shares took a step back after an early rally.Source: Shutterstock The Sunnyvale, Calif.-based manufacturer and marketer of robotic items said that for its second quarter of the fiscal year -- which ended June 30 -- it amassed adjusted earnings of $3.25 per share. This amount was about 18% higher than they were during the same period a year ago.Intuitive Surgical also brought in a profit that surpassed the Wall Street consensus estimate of $2.85 per share, according to data compiled by Zacks Investment Research. Sales were higher as well, reaching about $1.1 billion, a 21% gain when stacked up against the same period in its previous fiscal year.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWall Street saw the business raking in revenue of $1.03 billion in its average guidance. "Our teams remain focused on helping our customers improve outcomes and lower the total cost to treat per patient episode for their patient populations," Intuitive Surgical Gary Guthart said in a written statement.The business benefited from growth in U.S. general surgery, as well as worldwide urology procedures, which were good for a growth of 17% in the number of procedures that used the da Vinci robotic surgery system.ISRG stock is down about 0.9% Friday following the company's quarterly earnings results. More From InvestorPlace * 10 Tech Stocks That Are Still Worth Your Time (And Money) * 7 Stocks Top Investors Are Buying Now * 9 Retail Stocks Goldman Sachs Says Are Ready to Rip * 10 Stocks to Sell for an Economic Slowdown The post Intuitive Surgical Earnings: ISRG Stock Down Despite Q2 Profit Beat appeared first on InvestorPlace.

  • This Key Trend Continues at Intuitive Surgical
    Motley Fool3 days ago

    This Key Trend Continues at Intuitive Surgical

    More hospitals are using this new method to get systems in-house.

  • Benzinga3 days ago

    Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts

    Canaccord Genuity analyst Jason Mills maintained a Buy rating on Intuitive Surgical and lifted the price target from $575 to $610. Stifel analyst Rick Wise rates the shares a Buy, with a $570 price target. Morgan Stanley analyst David Lewis reiterated an Overweight rating and $620 price target.

  • Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed
    Zacks3 days ago

    Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed

    Intuitive Surgical (ISRG) expects 2019 procedure growth within 16-17%.

  • Dow Jones Futures: After Fed-Led Stock Market Rally, Microsoft, Boeing, CrowdStrike Lead Big Movers
    Investor's Business Daily3 days ago

    Dow Jones Futures: After Fed-Led Stock Market Rally, Microsoft, Boeing, CrowdStrike Lead Big Movers

    Futures signaled more stock market rally gains. Boeing sees an end to 737 Max woes, Microsoft rallied on earnings. CrowdStrike, Skechers surged past buy points.

  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of ISRG earnings conference call or presentation 18-Jul-19 8:30pm GMT

    Q2 2019 Intuitive Surgical Inc Earnings Call

  • Intuitive Surgical Inc (ISRG) Q2 2019 Earnings Call Transcript
    Motley Fool3 days ago

    Intuitive Surgical Inc (ISRG) Q2 2019 Earnings Call Transcript

    ISRG earnings call for the period ending June 30, 2019.

  • Robotic Surgery Giant Crushes Earnings Views; Is A Breakout Possible?
    Investor's Business Daily4 days ago

    Robotic Surgery Giant Crushes Earnings Views; Is A Breakout Possible?

    Intuitive Surgical earnings of $3.25 per share beat estimates as $1.1 billion in sales also topped. But Intuitive Surgical stock slipped late Thursday.

  • GlobeNewswire4 days ago

    Intuitive Announces Second Quarter Earnings

    SUNNYVALE, Calif., July 18, 2019 -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,.

  • IBD's Investing Podcast: How To Make More Money In The Stock Market With Stock Charts
    Investor's Business Daily4 days ago

    IBD's Investing Podcast: How To Make More Money In The Stock Market With Stock Charts

    Investing with IBD is a weekly podcast focused on helping investors learn how to make more money in the stock market by using stock charts to find top stocks.

  • Investing.com4 days ago

    Intuitive Surgical Earnings, Revenue Beat in Q2

    Investing.com - Intuitive Surgical (NASDAQ:ISRG) reported second quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.

  • These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why
    Investor's Business Daily5 days ago

    These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why

    JNJ earnings report could be a boon for medical stocks Boston Scientific and Penumbra, an analyst said Wednesday. Boston has efforts in electrophysiology. Penumbra works in stroke treatment.

  • Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
    Zacks5 days ago

    Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?

    Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • The 5 Hottest Earnings Charts This Week
    Zacks6 days ago

    The 5 Hottest Earnings Charts This Week

    The 5 stocks have had the sizzle over the last 5 years. Will it continue this week?

  • Intuitive Surgical to Boost da Vinci Platform With Buyout
    Zacks6 days ago

    Intuitive Surgical to Boost da Vinci Platform With Buyout

    Intuitive Surgical's (ISRG) acquisition of Scholly Fiberoptic's robotic endoscope business to likely boost the acquirer's da Vinci Surgical system.

  • GlobeNewswire7 days ago

    Intuitive Surgical acquires Schölly Fiberoptic’s robotic endoscope business

    Intuitive (ISRG), the pioneer and a global leader in robotic-assisted, minimally invasive surgery and manufacturer of da Vinci surgical systems, today announced the acquisition of Schölly Fiberoptic’s robotic endoscope business. Intuitive is acquiring the robotic endoscope portion of Schölly Fiberoptic’s business.

  • Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Overpaying Its CEO?
    Simply Wall St.7 days ago

    Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Overpaying Its CEO?

    In 2010 Gary Guthart was appointed CEO of Intuitive Surgical, Inc. (NASDAQ:ISRG). This analysis aims first to contrast...

  • 3 Brand-Name Growth Stocks That Keep Getting Better With Age
    Motley Fool7 days ago

    3 Brand-Name Growth Stocks That Keep Getting Better With Age

    Margins for these top growth stocks should significantly improve over time.

  • Benzinga9 days ago

    The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings

    Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts . Pharma and biotech stocks took comfort in a ruling by a federal judge that went against President Donald ...

  • Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know
    Zacks10 days ago

    Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know

    Intuitive Surgical (ISRG) closed the most recent trading day at $526.25, moving -1.82% from the previous trading session.

  • 4 Healthcare Stocks That Are Feeling Sick
    InvestorPlace10 days ago

    4 Healthcare Stocks That Are Feeling Sick

    While the broad U.S. equity market is pushing confidently to new all-time highs, healthcare stocks are lagging badly. The entire sector has come under pressure after President Donald Trump's effort to lower drug prices high a legal roadblock when a judge blocked a new requirement to list prices in commercials. The Trump Administration also reversed its plan to curb drug rebates for government healthcare plans.The pressure isn't slowing down, with the Health Care Select SPDR (NYSEARCA:XLV) cutting down out of a multi-week consolidation range to put an end to a three-month uptrend. This also marks a turnaround at resistance from the early December highs and sets up a decline back to the mid-April lows. * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond A number of big players in the sector are lagging badly. Here are four healthcare stocks to sell now:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare Stocks to Sell: Johnson & Johnson (JNJ)Shares of Johnson & Johnson (NYSE:JNJ) are dropping hard, down more than 4% on Friday as I write this and returning to lows not seen since early June. The move cuts below the stock's 200-day moving average and marks an inability to challenge the prior highs from back in December. The company continues to be dogged by legal risks related to baby powder asbestos claims.The company will next report results on July 16 before the bell. Analysts are looking for earnings of $2.42 per share on revenues of $20.4 billion. When the company last reported on April 16, earnings of $2.10 beat estimates by six cents on a 0.1% rise in revenues. Abbott Laboratories (ABT)Abbott Laboratories (NYSE:ABT) shares have fallen below their 20-day moving average for the first time since late May in what looks like the latest pullback within a secular uptrend that has been in play since 2016. Barclays analysts recently highlighted the company's impressive 7.1% organic revenue growth rate but noted very high investor expectations. Some profit taking should be expected. * 10 Stocks Driving the Market to All-Time Highs (And Why) The company will next report results on July 17 before the bell. Analysts are looking for earnings of 80 cents per share on revenues of $8 billion. When the company last reported on April 17, earnings of 63 cents per share beat estimates by a penny on a 2% rise in revenues. Intuitive Surgical (ISRG)Shares of Intuitive Surgical (NASDAQ:ISRG) are threatening to fall back below their 200-day moving average after struggling to reclaim that level after a nasty 22% decline from its mid-April high. This marks a continuation of a sideways range going back to the summer of 2018. The company is a maker of robotic surgical systems.The company will next report results on July 18 after the close. Analysts are looking for earnings of $2.87 per share on revenues of just over $1 billion. When the company last reported on April 18, earnings of $2.61 missed estimates by nine cents on a 14.9% rise in revenues. Illumnia (ILMN)Shares of Illumnia (NASDAQ:ILMN), which provides sequencing solutions for genetic analysis, is suffering a decline of more than 16% in mid-day trading after management guided second-quarter revenues below consensus estimates. Sales growth was impacted by lower than expected contributions from genomics initiatives. Shares were downgraded by analysts at Bank of America Merrill Lynch from buy to sell. Earlier this week, the stock hit an all-time high. * 7 Retail Stocks to Buy for the Second Half of 2019 ISRG stock will next report results on July 29 after the close. Analysts are looking for earnings of $1.42 per share on revenues of $885.6 million. When the company last reported on April 25, earnings of $2.56 beat estimates by 30 cents per share on an 8.2% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy for Less Than Book * 7 Marijuana Stocks With Critical Levels to Watch * The 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The post 4 Healthcare Stocks That Are Feeling Sick  appeared first on InvestorPlace.